港股通创新药ETF汇添富(159570)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
9,016.26 |
12,616,820.62 |
199,640,828.70 |
4,098.16 |
| 存出保证金 |
24,515,541.26 |
11,402.09 |
79,914,355.02 |
14.76 |
| 交易性金融资产 |
19,678,084,824.05 |
21,128,586,707.36 |
7,648,012,961.26 |
640,485,268.41 |
| 其中:股票投资 |
19,678,084,824.05 |
21,128,586,707.36 |
7,648,012,961.26 |
640,485,268.41 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
1,659,665.26 |
4,480,908.31 |
- |
2,600,370.76 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
66,037,395.52 |
- |
8,124,234.43 |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
20,037,121,035.19 |
21,538,794,705.31 |
8,122,897,789.84 |
656,523,342.78 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
34,539,435.04 |
37,281,218.29 |
316,741,898.16 |
2,902,511.52 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
8,347,790.42 |
9,738,794.46 |
2,362,655.12 |
269,430.75 |
| 应付托管费 |
1,669,558.10 |
1,947,758.90 |
472,531.01 |
53,886.15 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
3,593,890.05 |
1,667,190.36 |
1,405,775.46 |
216,804.89 |
| 负债合计 |
48,150,673.61 |
50,634,962.01 |
320,982,859.75 |
3,442,633.31 |
| 所有者权益 |
| 实收基金 |
15,780,597,142.00 |
13,830,597,142.00 |
5,128,597,142.00 |
681,597,142.00 |
| 未分配利润 |
4,208,373,219.58 |
7,657,562,601.30 |
2,673,317,788.09 |
-28,516,432.53 |
| 所有者权益合计 |
19,988,970,361.58 |
21,488,159,743.30 |
7,801,914,930.09 |
653,080,709.47 |
| 负债及所有者权益总计 |
20,037,121,035.19 |
21,538,794,705.31 |
8,122,897,789.84 |
656,523,342.78 |